{
  "main_header": {
    "sid": 739743,
    "name": "SPARC",
    "stock_name": "SPARC",
    "full_name": "Sun Pharma Advanced Research Company Ltd",
    "name_url": "stocks-analysis/sparc",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "131.40",
    "chg": 0.3,
    "chgp": "0.23%",
    "dir": 1,
    "prev_price": "131.10",
    "mcapval": "4,232.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532872,
    "symbol": "SPARC",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE232I01014",
    "curr_date": "Dec 18",
    "curr_time": "",
    "bse_nse_vol": "6.78 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 18, 2025",
    "traded_date_str": "2025 12 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sparc-739743-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Sun Pharma Advanced Research Company Faces Bearish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-faces-intensified-downtrend-amid-technical-weakness-3760721",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaAdvanc_technicaldot_3760721.png",
        "date": "2025-12-17 08:10:47",
        "description": "Sun Pharma Advanced Research Company (SPARC) is exhibiting a notable shift in price momentum as recent technical indicators reveal a predominantly bearish outlook. The stock’s performance contrasts sharply with broader market trends, underscoring challenges within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is SPARC falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sparc-fallingrising-3760441",
        "imagepath": "",
        "date": "2025-12-17 00:57:22",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>SPARC’s stock price closed at ₹132.80 on 16 December, down by ₹3.50 or 2.57% from the previous session. This decline continues a five-day losing streak, during which the stock has fallen by 6.45%. The intraday low touched ₹132.20, marking a 3.01% drop within the trading day. Notably, the stock has underperformed its sector by 2.04% today and is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum.</p>\n<p>Investor participation has also waned, with delivery volumes on 15 December falling sharply by 61.27% compared to the five-day average, indicating reduced buying interest. Despite this, liquidity remains adequate for trades up to ₹0.86 crore..."
      },
      {
        "title": "Sun Pharma Advanced Research Company Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-hits-intraday-low-amid-price-pressure-3751579",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaAdvanc_priceRelatedfactors_3751579.png",
        "date": "2025-12-08 13:33:46",
        "description": "Sun Pharma Advanced Research Company experienced a notable decline today, touching an intraday low of Rs 140.4, reflecting a price pressure of 8.15% during the session. This underperformance contrasted with broader market movements and sector trends, signalling immediate pressures on the stock."
      },
      {
        "title": "Sun Pharma Advanced Research Company Hits Intraday High with Strong Trading Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-hits-intraday-high-with-897-surge-3743288",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaAdvanc_priceRelatedfactors_3743288.png",
        "date": "2025-12-03 09:32:14",
        "description": "Sun Pharma Advanced Research Company recorded a robust intraday performance today, reaching a high of Rs 174.25, reflecting an 8.16% rise during the trading session. The stock outpaced its sector and broader market indices, demonstrating notable volatility and sustained upward momentum."
      },
      {
        "title": "Sun Pharma Advanced Research Company Surges with Unprecedented Buying Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-surges-20-on-unprecedented-buying-interest-3741831",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaAdvanc_only_buyers_3741831.png",
        "date": "2025-12-02 13:20:49",
        "description": "Sun Pharma Advanced Research Company Ltd has witnessed extraordinary buying momentum, with the stock hitting an upper circuit and only buy orders in the queue, signalling a potential multi-day rally amid strong investor enthusiasm."
      },
      {
        "title": "Sun Pharma Advanced Research Company Hits Intraday High with Strong Trading Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-hits-intraday-high-with-853-surge-3740922",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SunPharmaAdvanc_priceRelatedfactors_3740922.png",
        "date": "2025-12-02 09:32:05",
        "description": "Sun Pharma Advanced Research Company recorded a robust intraday performance today, reaching a high of Rs 145.95, reflecting an 8.72% rise amid heightened volatility and notable trading activity."
      },
      {
        "title": "SPARC’s Evaluation Revised Amidst Challenging Financial and Market Conditions",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sparc-downgraded-to-strong-sell-by-marketsmojo-amid-deteriorating-fundamentals-3735201",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SPARC_mojoScore_3735201.png",
        "date": "2025-11-28 10:05:12",
        "description": "SPARC, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing financial and operational challenges. This shift highlights the company’s current standing amid a difficult market environment and persistent underperformance relative to its peers and benchmarks."
      },
      {
        "title": "Sun Pharma Advanced Research Company Shows Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-shows-mixed-technical-signals-amid-prolonged-underperformance-3734623",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SunPharmaAdvanc_technicaldot_3734623.png",
        "date": "2025-11-28 08:04:36",
        "description": "Sun Pharma Advanced Research Company (SPARC) has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum. Recent data reveals a transition from a predominantly bearish stance to a mildly bearish outlook, with key technical indicators such as MACD, RSI, and moving averages presenting a complex picture for investors analysing the pharmaceutical and biotechnology sector."
      },
      {
        "title": "Sun Pharma Advanced Research Company Faces Technical Momentum Shift Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharma-advanced-research-company-faces-bearish-momentum-amid-technical-downturn-3727549",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SunPharmaAdvanc_technicaldot_3727549.png",
        "date": "2025-11-25 08:09:18",
        "description": "Sun Pharma Advanced Research Company (SPARC) is currently exhibiting a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent evaluation adjustments highlight a transition in key technical indicators, signalling a more cautious outlook for investors amid broader market pressures."
      }
    ],
    "total": 151,
    "sid": "739743",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharma-advanced-research-company-739743"
  },
  "announcements": [
    {
      "caption": "Clarification sought from Sun Pharma Advanced Research Company Ltd",
      "datetime": "03-Dec-2025",
      "details": "The Exchange has sought clarification from Sun Pharma Advanced Research Company Ltd on December 03 2025 with reference to Movement in Volume.<BR><BR>The reply is awaited.",
      "source": "BSE"
    },
    {
      "caption": "Clarification Regarding Increase In The Volume",
      "datetime": "03-Dec-2025",
      "details": "Response of Clarification sought from BSE Limited",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "02-Dec-2025",
      "details": "SPARC Announces the U.S. District Court Grants Summary Judgement in Favour of SPARC for Sezaby PRV",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharma Advanced Research Company Ltd has announced <strong>5:116</strong> rights issue, ex-date: 16 Mar 16",
          "dt": "2016-03-16",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Sun Pharma Advanced Research Company Faces Bearish Momentum Amid Technical Shifts

2025-12-17 08:10:47

Sun Pharma Advanced Research Company (SPARC) is exhibiting a notable shift in price momentum as recent technical indicators reveal a predominantly bearish outlook. The stock’s performance contrasts sharply with broader market trends, underscoring challenges within the Pharmaceuticals & Biotechnology sector.

Read More

Why is SPARC falling/rising?

2025-12-17 00:57:22

Recent Price Movement and Market Performance

SPARC’s stock price closed at ₹132.80 on 16 December, down by ₹3.50 or 2.57% from the previous session. This decline continues a five-day losing streak, during which the stock has fallen by 6.45%. The intraday low touched ₹132.20, marking a 3.01% drop within the trading day. Notably, the stock has underperformed its sector by 2.04% today and is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum.

Investor participation has also waned, with delivery volumes on 15 December falling sharply by 61.27% compared to the five-day average, indicating reduced buying interest. Despite this, liquidity remains adequate for trades up to ₹0.86 crore...

Read More

Sun Pharma Advanced Research Company Hits Intraday Low Amid Price Pressure

2025-12-08 13:33:46

Sun Pharma Advanced Research Company experienced a notable decline today, touching an intraday low of Rs 140.4, reflecting a price pressure of 8.15% during the session. This underperformance contrasted with broader market movements and sector trends, signalling immediate pressures on the stock.

Read More

Sun Pharma Advanced Research Company Hits Intraday High with Strong Trading Momentum

2025-12-03 09:32:14

Sun Pharma Advanced Research Company recorded a robust intraday performance today, reaching a high of Rs 174.25, reflecting an 8.16% rise during the trading session. The stock outpaced its sector and broader market indices, demonstrating notable volatility and sustained upward momentum.

Read More

Sun Pharma Advanced Research Company Surges with Unprecedented Buying Interest

2025-12-02 13:20:49

Sun Pharma Advanced Research Company Ltd has witnessed extraordinary buying momentum, with the stock hitting an upper circuit and only buy orders in the queue, signalling a potential multi-day rally amid strong investor enthusiasm.

Read More

Sun Pharma Advanced Research Company Hits Intraday High with Strong Trading Momentum

2025-12-02 09:32:05

Sun Pharma Advanced Research Company recorded a robust intraday performance today, reaching a high of Rs 145.95, reflecting an 8.72% rise amid heightened volatility and notable trading activity.

Read More

SPARC’s Evaluation Revised Amidst Challenging Financial and Market Conditions

2025-11-28 10:05:12

SPARC, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting ongoing financial and operational challenges. This shift highlights the company’s current standing amid a difficult market environment and persistent underperformance relative to its peers and benchmarks.

Read More

Sun Pharma Advanced Research Company Shows Mixed Technical Signals Amid Price Momentum Shift

2025-11-28 08:04:36

Sun Pharma Advanced Research Company (SPARC) has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum. Recent data reveals a transition from a predominantly bearish stance to a mildly bearish outlook, with key technical indicators such as MACD, RSI, and moving averages presenting a complex picture for investors analysing the pharmaceutical and biotechnology sector.

Read More

Sun Pharma Advanced Research Company Faces Technical Momentum Shift Amid Market Challenges

2025-11-25 08:09:18

Sun Pharma Advanced Research Company (SPARC) is currently exhibiting a notable shift in its technical momentum, reflecting evolving market dynamics within the Pharmaceuticals & Biotechnology sector. Recent evaluation adjustments highlight a transition in key technical indicators, signalling a more cautious outlook for investors amid broader market pressures.

Read More

View All News